SlideShare a Scribd company logo
SUNY Empire State College
   Jason Gabari RN PCCN
Learning Objectives
 Discuss the reason for using ACE Inhibitors and the
  mechanism by which they work.
 Identify three common adverse effects of using ACE
  Inhibitors.
 Identify three considerations for educating a patient
  on the use of ACE Inhibitors
ACE Inhibitors
 ACE Inhibitors are medications that belong in the
  class of medications known as antihypertensive
  medications.
 ACE Inhibitors work on the Renin-Angiotensin-
  Aldosterone System
Renin-Angiotensin-Aldosterone System
 A system which works to increase blood pressure when the
    pressure within the kidneys drops.
   As a result of low blood pressure and/or oxygenation in the
    nephron, renin is released from the juxtaglomerular cells.
   Renin travels to the liver via the cardiovascular system and
    combines with angiotensinogen to form angiotensin I.
   Angiotensin I travels through the cardiovascular system
    and arrives at the lungs where it is changed into
    Angiotensin II.
   The alveoli use Angiotensin Converting Enzyme also
    known as kinase II to cause this conversion.
    (Karch, 2012, pg. 671)
Renin-Angiotensin-Aldosterone System cont.
 Angiotensin II is a powerful vasoconstrictor which
  causes a rise in peripheral resistance and increases
  pressure.
 Angiotensin II works to increase the release of
  aldosterone from the adrenal glands.
 Aldosterone causes renal retention of sodium and
  water, which further increases blood pressure by
  increasing volume. (Karch, 2012, pg. 671)
Mechanism of Action for ACE Inhibitors
 ACE Inhibitors work in the lungs to inhibit
  Angiotensin Converting Enzyme from turning
  Angiotensin I into Angiotensin II.
 These medications cause an increase of
  bradykinin, which inhibits kinase II, another name for
  Angiotensin Converting Enzyme. (Lehne, 2007, pg.
  464)
 Blood Pressure is decreased due to a decrease in blood
  volume, peripheral resistance, and cardiac load.
 ACE Inhibitors, inhibit vasoconstriction and release of
  aldosterone which inhibits the retention of sodium
  and water.
Indications For Use
 Hypertension-used especially for malignant
 hypertension and hypertension secondary to renal
 arterial stenosis.
       Benefits of Using an ACE Inhibitor
           Do not interfere with cardiovascular reflexes

           Do not interfere with patients who have asthma like beta-
            blockers
           Do not decrease potassium levels.

           Do not cause lethargy, weakness and sexual dysfunction.

           “ACE inhibitors reduce the risk of cardiovascular mortality
            caused by hypertension.” (Lehne, ,2007, pg. 465)
Indications For Use cont.
 Heart Failure
       By decreasing arteriolar tone region blood flow to the heart
        improves.
       By decreasing afterload, cardiac output increases.
       Venous dilation increases causing a decrease in pulmonary
        congestion and peripheral edema.
       Dilates the vessels of the kidneys increasing renal flow and
        helps to excrete sodium and water. This helps to decrease
        edema and blood volume.
       Prevents pathologic changes in the heart that result from
        reducing the angiotensin II levels in the heart.
        (Lehne, 2007, pg. 465)
Indications For Use cont.
 Myocardial Infarction (MI)
       Decreases the chance of heart failure after an MI.
       Should be given for 6 weeks post MI. If heart failure occurs it
        should be considered for permanent use.
 Nephropathy
       Slows renal disease of diabetic or nondiabetic origins
       Decreases glomerular filtration pressure.
Indications For Use cont.
 Type 2 Diabetes
       Decreases morbidity in high risk patients.
       Increased levels of angiotensin II have a correlation to type 2
        diabetes.
       ACE inhibitors increase kinin levels, which increase
        production of prostaglandins and nitric oxide.
       Prostaglandins and nitric oxide improve muscular sensitivity
        to insulin. (Solski & Longyhore, 2008, pg. 936)
       May preserve pancreatic function and prevent onset of
        diabetes especially with people who have hypertension.
Common Trade Names
Generic Name       Trade Name
   benazepril        Lotensin
   captopril         Capoten
   enalapril         Vasotec
   enalaprilat       Vasotec IV
   fosinopril        Monopril
   lisinopril        Prinivil, Zestril
   moexipril         Univasc
   perinodopril      Aceon
   quinapril         Accupril
   ramipril          Altace
Adverse Effects
 First-Dose Hypotension
       Usually occurs with initial dose.
       Worse in patients with severe hypertension, or are on
        diuretics, or are sodium or volume depleted.
 Cough
       “Persistent, dry, irritating, nonproductive cough can develop
        with all ACE inhibitors.” (Lehne, 2007, pg. 466)
       Due to rise in bradykinin which occurs due to inhibition of
        kinase II.
       Occurs in 5-10% of patients and is more common in women
        and the elderly.
Adverse Effects cont.
 Hyperkalemia
       Potassium levels rise due to the inhibition of
        aldosterone, which causes potassium to be retained by the
        kidneys.
 Renal Failure
       Can cause renal insufficiency in people who have bilateral
        renal artery stenosis, because dropping the pressure in the
        renal arteries in these patients can cause glomerular
        filtration to fail.
 Fetal Injury
       In the second and third trimesters a fetus can experience
        hypotension, hyperkalemia, skull hypoplasia, renal
        failure, and death.
Drug Interactions
 Antihypertensive agents
       Can cause an increased effect of medications especially with
        diuretics.
 Potassium increasing medications
       Cause an increased risk of hyperkalemia due to the suppression of
        aldosterone.
 Lithium
       Increases to risk of lithium toxicity.
 Allopurinol
       Increases hypersensitivity to medication
 NSAIDS
       Reduce antihypertensive effects of medication.
Nursing Considerations
 Encourage lifestyle changes
        Weight loss
        Quit smoking
        Decrease alcohol intake
        Encourage exercise to help lower blood pressure
 Monitor Renal Function
        BUN, Creatinine, and Potassium levels
 Monitor for decreased fluid volume which can bottom our
  blood pressure
        Excessive sweating
        Diarrhea
        Vomiting
        Dehydration
Nursing Considerations cont.
 Monitor for 1st-dose hypotension
        May have to stop other antihypertensive medications at initiation of
         ACE inhibitors.
        May have to give these medications in lower doses going forward.
        Discontinue diuretics for 2-3 days prior to starting an ACE inhibitor.
        Monitor BP for several hours and if patient becomes hypotensive lay
         patient supine and consider discussing IV bolus of saline with the
         MD.
 Educate Patient
        Teach the patient about the medication including name adverse
         effects, drug interactions.
        Teach the patient about the signs of hypotension, hyperkalemia, and
         renal failure. If patient is taking lithium discuss the signs of lithium
         toxicity.
Test Questions
1.    Which of these patients would most likely be treated
      with an ACE inhibitor?
     a) A 38-year old women who has become hypertensive in
        the last trimester of her pregnancy.
     b) A 78-year old man who just had a heart attack and is in
        renal failure.
     c) A 60-year old man who is a diabetic and suffers from
        hypertension.
     d) A 72-year old female with a history of hypertenstion
        who comes to the ER in septic shock.
Test Questions
2. Which statement by a patient taking ACE inhibitors
   demonstrates the patient’s understanding of the
   medication?
  a) “I don’t need to exercise because the medication will
     make me better.”
  b) “If I feel weak or faint I should take my
     medication, because it will make me feel better.”
  c) “I can use salt substitutes instead of the real thing.”
  d) “If I develop a cough that does not go away I should
     call my doctor.”
Test Questions
1.   Which of these lab values would be a
     contraindication for taking an ACE inhibitor?
     a) Potassium 3.3
     b) Potassium 5.6
     c) BUN 10
     d) Creatinine 1.2
Test Answers with Rationale
1. c is the correct answer. a, b, and d all have
   contraindications for giving an ACE inhibitor.
2. d is the correct answer. a is wrong because exercise
   should be encouraged. b is wrong because weakness
   and syncope are signs that the patient may be
   hypotensive. c is wrong because salt substitutes are
   high in potassium and should be used with caution
   in patients on ACE inhibitors.
3. a is the right answer. Hyperkalemia is a
   contraindication for ACE inhibitors.
References
 Karch, A. (2011). Focus on nursing pharmacology (5th
      ed.). Philadephia, PA: Wolters Kluwer | Lippincott
      Williams & Wilkins.
 Lehne, R. (2007). Pharmacology for nursing care (6th ed.).
      St. Louis, MO: Saunders|Elsevier.
 Solski, L. V. & Longyhore. (2008). Prevention of type 2
      diabetes mellitus with angiotensin-converting-
      enzyme inhibitors. American Journal of Health-
      System Pharmacy, 65(10): 935-40.
 Waterfield, J. (2008). ACE inhibitors: use, action, and
      prescribing rationale. Nurse Prescribing, 6(3): 110-4.

More Related Content

What's hot (20)

Drugs used in Congestive heart failure
Drugs used in Congestive heart failure Drugs used in Congestive heart failure
Drugs used in Congestive heart failure
shoaib241087
 
Antihypertensives
AntihypertensivesAntihypertensives
Antihypertensives
raj kumar
 
Antiarrhythmic drugs bds
Antiarrhythmic drugs bdsAntiarrhythmic drugs bds
Antiarrhythmic drugs bds
Naser Tadvi
 
Antiplatelet drugs
Antiplatelet drugsAntiplatelet drugs
Antiplatelet drugs
pradnya Jagtap
 
Pharmacology of Antiarrhythmic drugs
Pharmacology of Antiarrhythmic drugsPharmacology of Antiarrhythmic drugs
Pharmacology of Antiarrhythmic drugs
Koppala RVS Chaitanya
 
Antianginal Drugs
Antianginal DrugsAntianginal Drugs
Antianginal Drugs
Subramani Parasuraman
 
Angiotensin receptor blockers
Angiotensin receptor blockersAngiotensin receptor blockers
Angiotensin receptor blockers
Mahatma Gandhi Medical College & Hospital
 
Calcium Channel Blockers
Calcium Channel Blockers Calcium Channel Blockers
Calcium Channel Blockers
Dr Htet
 
Drugs for heart failure
Drugs for heart failureDrugs for heart failure
Drugs for heart failure
BikashAdhikari26
 
Vasodilators - Medicinal chemistry for B.Pharm.
Vasodilators - Medicinal chemistry for B.Pharm.Vasodilators - Medicinal chemistry for B.Pharm.
Vasodilators - Medicinal chemistry for B.Pharm.
Purna Nagasree K
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
Subramani Parasuraman
 
Pharmacology of Anti platelet drugs
Pharmacology of Anti platelet drugsPharmacology of Anti platelet drugs
Pharmacology of Anti platelet drugs
Dr. Advaitha MV
 
Pharmacological management of heart failure
Pharmacological management of heart failurePharmacological management of heart failure
Pharmacological management of heart failure
Naser Tadvi
 
Antiplatelet drugs (antithrombotics)
Antiplatelet drugs (antithrombotics)Antiplatelet drugs (antithrombotics)
Antiplatelet drugs (antithrombotics)
http://neigrihms.gov.in/
 
Propranolol
PropranololPropranolol
Propranolol
Md Shohag Hosen
 
Antihyperlipidemic agents
Antihyperlipidemic agentsAntihyperlipidemic agents
Antihyperlipidemic agents
kencha swathi
 
Antiplatelet Drugs
Antiplatelet DrugsAntiplatelet Drugs
Antiplatelet Drugs
Lady Hardinge Medical College
 
Oral hypoglycemics
Oral hypoglycemicsOral hypoglycemics
Oral hypoglycemics
ankit
 
Beta blockers
Beta blockersBeta blockers
Beta blockers
Naser Tadvi
 
Calcium channel blockers
Calcium channel blockersCalcium channel blockers
Calcium channel blockers
SurendraKumar338
 

Viewers also liked (6)

Angiotensin Converting Enzyme Inhibitors
Angiotensin Converting Enzyme InhibitorsAngiotensin Converting Enzyme Inhibitors
Angiotensin Converting Enzyme Inhibitors
alexandria university, faculty of medicine
 
Trials of ace inhibitors
Trials of ace inhibitorsTrials of ace inhibitors
Trials of ace inhibitors
Dharam Prakash Saran
 
ACE Inhibitors
ACE InhibitorsACE Inhibitors
ACE Inhibitors
Diksha Kumari
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
DrVishal Kandhway
 
The renin angiotensin aldosterone system.
The renin angiotensin aldosterone system.The renin angiotensin aldosterone system.
The renin angiotensin aldosterone system.
https://aiimsbhubaneswar.nic.in/
 
Drugs acting on Renin Angiotensin Aldosterone system
Drugs acting on Renin Angiotensin Aldosterone system Drugs acting on Renin Angiotensin Aldosterone system
Drugs acting on Renin Angiotensin Aldosterone system
Dr Htet
 

Similar to Ace inhibitors (20)

The Renin-Angiotensin System is a hormonal system that helps regulate blood p...
The Renin-Angiotensin System is a hormonal system that helps regulate blood p...The Renin-Angiotensin System is a hormonal system that helps regulate blood p...
The Renin-Angiotensin System is a hormonal system that helps regulate blood p...
AbhishekRajput1310
 
Aceinhibitors
AceinhibitorsAceinhibitors
Aceinhibitors
Nuthan DeSouza
 
Ace
AceAce
Ace
Mahatma Gandhi Medical College & Hospital
 
Pharmacology Cardiovascular Drugs
Pharmacology   Cardiovascular DrugsPharmacology   Cardiovascular Drugs
Pharmacology Cardiovascular Drugs
pinoy nurze
 
NurseReview.Org Pharmacology Cardiovascular Drugs
NurseReview.Org Pharmacology  Cardiovascular DrugsNurseReview.Org Pharmacology  Cardiovascular Drugs
NurseReview.Org Pharmacology Cardiovascular Drugs
Nurse ReviewDotOrg
 
Congestive heart failure
Congestive heart failure Congestive heart failure
Congestive heart failure
Kanchan Devi
 
Reaction Paper On Ramipril
Reaction Paper On RamiprilReaction Paper On Ramipril
Reaction Paper On Ramipril
Olga Bautista
 
Case study.
Case study.Case study.
Case study.
Carmela Alonzo
 
ACE Inhibitors
ACE InhibitorsACE Inhibitors
ACE Inhibitors
Dr Yasar Khan
 
160465212 case-study-new-03
160465212 case-study-new-03160465212 case-study-new-03
160465212 case-study-new-03
homeworkping7
 
Ace inhibitor
Ace inhibitorAce inhibitor
Ace inhibitor
DeepaKarn
 
Hypertension
HypertensionHypertension
Hypertension
Tosca Torres
 
Q-1The disease process I chose for this article is the treatment.docx
Q-1The disease process I chose for this article is the treatment.docxQ-1The disease process I chose for this article is the treatment.docx
Q-1The disease process I chose for this article is the treatment.docx
woodruffeloisa
 
Htn05
Htn05Htn05
Htn05
pharmdude
 
Anti - Hypertensive agent/ Drug
Anti - Hypertensive agent/ Drug Anti - Hypertensive agent/ Drug
Anti - Hypertensive agent/ Drug
mounrafayel
 
1. Drug acting on CVS.pptxhhhhhhhhhhhhhhhh
1. Drug acting on CVS.pptxhhhhhhhhhhhhhhhh1. Drug acting on CVS.pptxhhhhhhhhhhhhhhhh
1. Drug acting on CVS.pptxhhhhhhhhhhhhhhhh
tabimedlife
 
Ppt on hypertension
Ppt on hypertensionPpt on hypertension
Ppt on hypertension
pawan kumar
 
ACE Inhibitors and receptor blockers.pptx
ACE Inhibitors and receptor blockers.pptxACE Inhibitors and receptor blockers.pptx
ACE Inhibitors and receptor blockers.pptx
Haider Ali
 
ACE - Inhibitors
ACE - InhibitorsACE - Inhibitors
ACE - Inhibitors
Thirivikkiraman zanaguiram
 
Antihypertensive lecture
Antihypertensive lecture Antihypertensive lecture
Antihypertensive lecture
syed tanveer shahzad
 
The Renin-Angiotensin System is a hormonal system that helps regulate blood p...
The Renin-Angiotensin System is a hormonal system that helps regulate blood p...The Renin-Angiotensin System is a hormonal system that helps regulate blood p...
The Renin-Angiotensin System is a hormonal system that helps regulate blood p...
AbhishekRajput1310
 
Pharmacology Cardiovascular Drugs
Pharmacology   Cardiovascular DrugsPharmacology   Cardiovascular Drugs
Pharmacology Cardiovascular Drugs
pinoy nurze
 
NurseReview.Org Pharmacology Cardiovascular Drugs
NurseReview.Org Pharmacology  Cardiovascular DrugsNurseReview.Org Pharmacology  Cardiovascular Drugs
NurseReview.Org Pharmacology Cardiovascular Drugs
Nurse ReviewDotOrg
 
Congestive heart failure
Congestive heart failure Congestive heart failure
Congestive heart failure
Kanchan Devi
 
Reaction Paper On Ramipril
Reaction Paper On RamiprilReaction Paper On Ramipril
Reaction Paper On Ramipril
Olga Bautista
 
160465212 case-study-new-03
160465212 case-study-new-03160465212 case-study-new-03
160465212 case-study-new-03
homeworkping7
 
Ace inhibitor
Ace inhibitorAce inhibitor
Ace inhibitor
DeepaKarn
 
Q-1The disease process I chose for this article is the treatment.docx
Q-1The disease process I chose for this article is the treatment.docxQ-1The disease process I chose for this article is the treatment.docx
Q-1The disease process I chose for this article is the treatment.docx
woodruffeloisa
 
Anti - Hypertensive agent/ Drug
Anti - Hypertensive agent/ Drug Anti - Hypertensive agent/ Drug
Anti - Hypertensive agent/ Drug
mounrafayel
 
1. Drug acting on CVS.pptxhhhhhhhhhhhhhhhh
1. Drug acting on CVS.pptxhhhhhhhhhhhhhhhh1. Drug acting on CVS.pptxhhhhhhhhhhhhhhhh
1. Drug acting on CVS.pptxhhhhhhhhhhhhhhhh
tabimedlife
 
Ppt on hypertension
Ppt on hypertensionPpt on hypertension
Ppt on hypertension
pawan kumar
 
ACE Inhibitors and receptor blockers.pptx
ACE Inhibitors and receptor blockers.pptxACE Inhibitors and receptor blockers.pptx
ACE Inhibitors and receptor blockers.pptx
Haider Ali
 

Recently uploaded (20)

Designing for Menopause: How to Design with Empathy for People in Transition
Designing for Menopause: How to Design with Empathy for People in TransitionDesigning for Menopause: How to Design with Empathy for People in Transition
Designing for Menopause: How to Design with Empathy for People in Transition
1508 A/S
 
PROCEDURE OF INTERSTITIAL BRACHYTHERAPY FOR SKIN AND BUCCAL MUCOSA UNDER LOCA...
PROCEDURE OF INTERSTITIAL BRACHYTHERAPY FOR SKIN AND BUCCAL MUCOSA UNDER LOCA...PROCEDURE OF INTERSTITIAL BRACHYTHERAPY FOR SKIN AND BUCCAL MUCOSA UNDER LOCA...
PROCEDURE OF INTERSTITIAL BRACHYTHERAPY FOR SKIN AND BUCCAL MUCOSA UNDER LOCA...
Kanhu Charan
 
Post-exercise thermoregulation and associated factors
Post-exercise thermoregulation and associated factorsPost-exercise thermoregulation and associated factors
Post-exercise thermoregulation and associated factors
Prof. Walid Kamal
 
Adulterants screening in Herbal products using Modern Analytical Techniques
Adulterants screening in Herbal products using Modern Analytical TechniquesAdulterants screening in Herbal products using Modern Analytical Techniques
Adulterants screening in Herbal products using Modern Analytical Techniques
28SamruddhiKadam
 
Psychopharmacological Agents Presentation.pptx
Psychopharmacological Agents Presentation.pptxPsychopharmacological Agents Presentation.pptx
Psychopharmacological Agents Presentation.pptx
Gauri Gawande
 
Brihat Vangeshwara Rasa, Shwasa Kasa Chintamani Rasa, Arogya vardhini Vati.pptx
Brihat Vangeshwara Rasa, Shwasa Kasa Chintamani Rasa, Arogya vardhini Vati.pptxBrihat Vangeshwara Rasa, Shwasa Kasa Chintamani Rasa, Arogya vardhini Vati.pptx
Brihat Vangeshwara Rasa, Shwasa Kasa Chintamani Rasa, Arogya vardhini Vati.pptx
Sågãr Búmtàrîyā
 
Mission Nutrition RETREAT Spring 2024.pptx
Mission Nutrition RETREAT Spring 2024.pptxMission Nutrition RETREAT Spring 2024.pptx
Mission Nutrition RETREAT Spring 2024.pptx
JessShirley3
 
APRIL 2025 Oncology Cartoons by Dr Kanhu Charan Patro
APRIL 2025 Oncology Cartoons by Dr Kanhu Charan PatroAPRIL 2025 Oncology Cartoons by Dr Kanhu Charan Patro
APRIL 2025 Oncology Cartoons by Dr Kanhu Charan Patro
Kanhu Charan
 
Medicinal Plants _25.ppt by prof of iitd
Medicinal Plants _25.ppt by prof of iitdMedicinal Plants _25.ppt by prof of iitd
Medicinal Plants _25.ppt by prof of iitd
jayadangolia
 
Partial Reprogramming (OSK) Research Summary
Partial Reprogramming (OSK) Research SummaryPartial Reprogramming (OSK) Research Summary
Partial Reprogramming (OSK) Research Summary
maximuspeto
 
Nerve Physiology - Nerve Action Potential
Nerve Physiology - Nerve Action PotentialNerve Physiology - Nerve Action Potential
Nerve Physiology - Nerve Action Potential
MedicoseAcademics
 
Hepatorenal Syndrome.pptx hepatorenal syndrome
Hepatorenal Syndrome.pptx hepatorenal syndromeHepatorenal Syndrome.pptx hepatorenal syndrome
Hepatorenal Syndrome.pptx hepatorenal syndrome
wxtbzvjypr
 
Unlocking the Secrets of the Skeletal System: Relevance for Nursing
Unlocking the Secrets of the Skeletal System: Relevance for NursingUnlocking the Secrets of the Skeletal System: Relevance for Nursing
Unlocking the Secrets of the Skeletal System: Relevance for Nursing
Viresh Mahajani
 
Ranitidine Recall:- Regulatory Response to NDMA Contamination
Ranitidine Recall:- Regulatory Response to NDMA ContaminationRanitidine Recall:- Regulatory Response to NDMA Contamination
Ranitidine Recall:- Regulatory Response to NDMA Contamination
Suyash Jain
 
#BRAINWAVE LEARNING pdf by #SM - #Sujitha #mohitha (doctor of pharmacy 💊) #ph...
#BRAINWAVE LEARNING pdf by #SM - #Sujitha #mohitha (doctor of pharmacy 💊) #ph...#BRAINWAVE LEARNING pdf by #SM - #Sujitha #mohitha (doctor of pharmacy 💊) #ph...
#BRAINWAVE LEARNING pdf by #SM - #Sujitha #mohitha (doctor of pharmacy 💊) #ph...
Mohithakumaran
 
Surgical anatomy, chest mechanics and Underwater seal mechanics
Surgical anatomy, chest mechanics and Underwater seal mechanicsSurgical anatomy, chest mechanics and Underwater seal mechanics
Surgical anatomy, chest mechanics and Underwater seal mechanics
reaganbennedictodur
 
Red Blood Cell indices and clinical implication
Red Blood Cell indices and clinical implicationRed Blood Cell indices and clinical implication
Red Blood Cell indices and clinical implication
MedicoseAcademics
 
Acute Bacterial Meningitis in Children.ppt
Acute Bacterial Meningitis in Children.pptAcute Bacterial Meningitis in Children.ppt
Acute Bacterial Meningitis in Children.ppt
AshwaniSood12
 
2025-04-09 ICPM_Amsterdam_Alain van Gool.pdf
2025-04-09 ICPM_Amsterdam_Alain van Gool.pdf2025-04-09 ICPM_Amsterdam_Alain van Gool.pdf
2025-04-09 ICPM_Amsterdam_Alain van Gool.pdf
Alain van Gool
 
Antibiotics Stewardship:IMA Awareness Drive
Antibiotics Stewardship:IMA Awareness DriveAntibiotics Stewardship:IMA Awareness Drive
Antibiotics Stewardship:IMA Awareness Drive
SMS MEDICAL COLLEGE
 
Designing for Menopause: How to Design with Empathy for People in Transition
Designing for Menopause: How to Design with Empathy for People in TransitionDesigning for Menopause: How to Design with Empathy for People in Transition
Designing for Menopause: How to Design with Empathy for People in Transition
1508 A/S
 
PROCEDURE OF INTERSTITIAL BRACHYTHERAPY FOR SKIN AND BUCCAL MUCOSA UNDER LOCA...
PROCEDURE OF INTERSTITIAL BRACHYTHERAPY FOR SKIN AND BUCCAL MUCOSA UNDER LOCA...PROCEDURE OF INTERSTITIAL BRACHYTHERAPY FOR SKIN AND BUCCAL MUCOSA UNDER LOCA...
PROCEDURE OF INTERSTITIAL BRACHYTHERAPY FOR SKIN AND BUCCAL MUCOSA UNDER LOCA...
Kanhu Charan
 
Post-exercise thermoregulation and associated factors
Post-exercise thermoregulation and associated factorsPost-exercise thermoregulation and associated factors
Post-exercise thermoregulation and associated factors
Prof. Walid Kamal
 
Adulterants screening in Herbal products using Modern Analytical Techniques
Adulterants screening in Herbal products using Modern Analytical TechniquesAdulterants screening in Herbal products using Modern Analytical Techniques
Adulterants screening in Herbal products using Modern Analytical Techniques
28SamruddhiKadam
 
Psychopharmacological Agents Presentation.pptx
Psychopharmacological Agents Presentation.pptxPsychopharmacological Agents Presentation.pptx
Psychopharmacological Agents Presentation.pptx
Gauri Gawande
 
Brihat Vangeshwara Rasa, Shwasa Kasa Chintamani Rasa, Arogya vardhini Vati.pptx
Brihat Vangeshwara Rasa, Shwasa Kasa Chintamani Rasa, Arogya vardhini Vati.pptxBrihat Vangeshwara Rasa, Shwasa Kasa Chintamani Rasa, Arogya vardhini Vati.pptx
Brihat Vangeshwara Rasa, Shwasa Kasa Chintamani Rasa, Arogya vardhini Vati.pptx
Sågãr Búmtàrîyā
 
Mission Nutrition RETREAT Spring 2024.pptx
Mission Nutrition RETREAT Spring 2024.pptxMission Nutrition RETREAT Spring 2024.pptx
Mission Nutrition RETREAT Spring 2024.pptx
JessShirley3
 
APRIL 2025 Oncology Cartoons by Dr Kanhu Charan Patro
APRIL 2025 Oncology Cartoons by Dr Kanhu Charan PatroAPRIL 2025 Oncology Cartoons by Dr Kanhu Charan Patro
APRIL 2025 Oncology Cartoons by Dr Kanhu Charan Patro
Kanhu Charan
 
Medicinal Plants _25.ppt by prof of iitd
Medicinal Plants _25.ppt by prof of iitdMedicinal Plants _25.ppt by prof of iitd
Medicinal Plants _25.ppt by prof of iitd
jayadangolia
 
Partial Reprogramming (OSK) Research Summary
Partial Reprogramming (OSK) Research SummaryPartial Reprogramming (OSK) Research Summary
Partial Reprogramming (OSK) Research Summary
maximuspeto
 
Nerve Physiology - Nerve Action Potential
Nerve Physiology - Nerve Action PotentialNerve Physiology - Nerve Action Potential
Nerve Physiology - Nerve Action Potential
MedicoseAcademics
 
Hepatorenal Syndrome.pptx hepatorenal syndrome
Hepatorenal Syndrome.pptx hepatorenal syndromeHepatorenal Syndrome.pptx hepatorenal syndrome
Hepatorenal Syndrome.pptx hepatorenal syndrome
wxtbzvjypr
 
Unlocking the Secrets of the Skeletal System: Relevance for Nursing
Unlocking the Secrets of the Skeletal System: Relevance for NursingUnlocking the Secrets of the Skeletal System: Relevance for Nursing
Unlocking the Secrets of the Skeletal System: Relevance for Nursing
Viresh Mahajani
 
Ranitidine Recall:- Regulatory Response to NDMA Contamination
Ranitidine Recall:- Regulatory Response to NDMA ContaminationRanitidine Recall:- Regulatory Response to NDMA Contamination
Ranitidine Recall:- Regulatory Response to NDMA Contamination
Suyash Jain
 
#BRAINWAVE LEARNING pdf by #SM - #Sujitha #mohitha (doctor of pharmacy 💊) #ph...
#BRAINWAVE LEARNING pdf by #SM - #Sujitha #mohitha (doctor of pharmacy 💊) #ph...#BRAINWAVE LEARNING pdf by #SM - #Sujitha #mohitha (doctor of pharmacy 💊) #ph...
#BRAINWAVE LEARNING pdf by #SM - #Sujitha #mohitha (doctor of pharmacy 💊) #ph...
Mohithakumaran
 
Surgical anatomy, chest mechanics and Underwater seal mechanics
Surgical anatomy, chest mechanics and Underwater seal mechanicsSurgical anatomy, chest mechanics and Underwater seal mechanics
Surgical anatomy, chest mechanics and Underwater seal mechanics
reaganbennedictodur
 
Red Blood Cell indices and clinical implication
Red Blood Cell indices and clinical implicationRed Blood Cell indices and clinical implication
Red Blood Cell indices and clinical implication
MedicoseAcademics
 
Acute Bacterial Meningitis in Children.ppt
Acute Bacterial Meningitis in Children.pptAcute Bacterial Meningitis in Children.ppt
Acute Bacterial Meningitis in Children.ppt
AshwaniSood12
 
2025-04-09 ICPM_Amsterdam_Alain van Gool.pdf
2025-04-09 ICPM_Amsterdam_Alain van Gool.pdf2025-04-09 ICPM_Amsterdam_Alain van Gool.pdf
2025-04-09 ICPM_Amsterdam_Alain van Gool.pdf
Alain van Gool
 
Antibiotics Stewardship:IMA Awareness Drive
Antibiotics Stewardship:IMA Awareness DriveAntibiotics Stewardship:IMA Awareness Drive
Antibiotics Stewardship:IMA Awareness Drive
SMS MEDICAL COLLEGE
 

Ace inhibitors

  • 1. SUNY Empire State College Jason Gabari RN PCCN
  • 2. Learning Objectives  Discuss the reason for using ACE Inhibitors and the mechanism by which they work.  Identify three common adverse effects of using ACE Inhibitors.  Identify three considerations for educating a patient on the use of ACE Inhibitors
  • 3. ACE Inhibitors  ACE Inhibitors are medications that belong in the class of medications known as antihypertensive medications.  ACE Inhibitors work on the Renin-Angiotensin- Aldosterone System
  • 4. Renin-Angiotensin-Aldosterone System  A system which works to increase blood pressure when the pressure within the kidneys drops.  As a result of low blood pressure and/or oxygenation in the nephron, renin is released from the juxtaglomerular cells.  Renin travels to the liver via the cardiovascular system and combines with angiotensinogen to form angiotensin I.  Angiotensin I travels through the cardiovascular system and arrives at the lungs where it is changed into Angiotensin II.  The alveoli use Angiotensin Converting Enzyme also known as kinase II to cause this conversion. (Karch, 2012, pg. 671)
  • 5. Renin-Angiotensin-Aldosterone System cont.  Angiotensin II is a powerful vasoconstrictor which causes a rise in peripheral resistance and increases pressure.  Angiotensin II works to increase the release of aldosterone from the adrenal glands.  Aldosterone causes renal retention of sodium and water, which further increases blood pressure by increasing volume. (Karch, 2012, pg. 671)
  • 6. Mechanism of Action for ACE Inhibitors  ACE Inhibitors work in the lungs to inhibit Angiotensin Converting Enzyme from turning Angiotensin I into Angiotensin II.  These medications cause an increase of bradykinin, which inhibits kinase II, another name for Angiotensin Converting Enzyme. (Lehne, 2007, pg. 464)  Blood Pressure is decreased due to a decrease in blood volume, peripheral resistance, and cardiac load.  ACE Inhibitors, inhibit vasoconstriction and release of aldosterone which inhibits the retention of sodium and water.
  • 7. Indications For Use  Hypertension-used especially for malignant hypertension and hypertension secondary to renal arterial stenosis.  Benefits of Using an ACE Inhibitor  Do not interfere with cardiovascular reflexes  Do not interfere with patients who have asthma like beta- blockers  Do not decrease potassium levels.  Do not cause lethargy, weakness and sexual dysfunction.  “ACE inhibitors reduce the risk of cardiovascular mortality caused by hypertension.” (Lehne, ,2007, pg. 465)
  • 8. Indications For Use cont.  Heart Failure  By decreasing arteriolar tone region blood flow to the heart improves.  By decreasing afterload, cardiac output increases.  Venous dilation increases causing a decrease in pulmonary congestion and peripheral edema.  Dilates the vessels of the kidneys increasing renal flow and helps to excrete sodium and water. This helps to decrease edema and blood volume.  Prevents pathologic changes in the heart that result from reducing the angiotensin II levels in the heart. (Lehne, 2007, pg. 465)
  • 9. Indications For Use cont.  Myocardial Infarction (MI)  Decreases the chance of heart failure after an MI.  Should be given for 6 weeks post MI. If heart failure occurs it should be considered for permanent use.  Nephropathy  Slows renal disease of diabetic or nondiabetic origins  Decreases glomerular filtration pressure.
  • 10. Indications For Use cont.  Type 2 Diabetes  Decreases morbidity in high risk patients.  Increased levels of angiotensin II have a correlation to type 2 diabetes.  ACE inhibitors increase kinin levels, which increase production of prostaglandins and nitric oxide.  Prostaglandins and nitric oxide improve muscular sensitivity to insulin. (Solski & Longyhore, 2008, pg. 936)  May preserve pancreatic function and prevent onset of diabetes especially with people who have hypertension.
  • 11. Common Trade Names Generic Name Trade Name  benazepril  Lotensin  captopril  Capoten  enalapril  Vasotec  enalaprilat  Vasotec IV  fosinopril  Monopril  lisinopril  Prinivil, Zestril  moexipril  Univasc  perinodopril  Aceon  quinapril  Accupril  ramipril  Altace
  • 12. Adverse Effects  First-Dose Hypotension  Usually occurs with initial dose.  Worse in patients with severe hypertension, or are on diuretics, or are sodium or volume depleted.  Cough  “Persistent, dry, irritating, nonproductive cough can develop with all ACE inhibitors.” (Lehne, 2007, pg. 466)  Due to rise in bradykinin which occurs due to inhibition of kinase II.  Occurs in 5-10% of patients and is more common in women and the elderly.
  • 13. Adverse Effects cont.  Hyperkalemia  Potassium levels rise due to the inhibition of aldosterone, which causes potassium to be retained by the kidneys.  Renal Failure  Can cause renal insufficiency in people who have bilateral renal artery stenosis, because dropping the pressure in the renal arteries in these patients can cause glomerular filtration to fail.  Fetal Injury  In the second and third trimesters a fetus can experience hypotension, hyperkalemia, skull hypoplasia, renal failure, and death.
  • 14. Drug Interactions  Antihypertensive agents  Can cause an increased effect of medications especially with diuretics.  Potassium increasing medications  Cause an increased risk of hyperkalemia due to the suppression of aldosterone.  Lithium  Increases to risk of lithium toxicity.  Allopurinol  Increases hypersensitivity to medication  NSAIDS  Reduce antihypertensive effects of medication.
  • 15. Nursing Considerations  Encourage lifestyle changes  Weight loss  Quit smoking  Decrease alcohol intake  Encourage exercise to help lower blood pressure  Monitor Renal Function  BUN, Creatinine, and Potassium levels  Monitor for decreased fluid volume which can bottom our blood pressure  Excessive sweating  Diarrhea  Vomiting  Dehydration
  • 16. Nursing Considerations cont.  Monitor for 1st-dose hypotension  May have to stop other antihypertensive medications at initiation of ACE inhibitors.  May have to give these medications in lower doses going forward.  Discontinue diuretics for 2-3 days prior to starting an ACE inhibitor.  Monitor BP for several hours and if patient becomes hypotensive lay patient supine and consider discussing IV bolus of saline with the MD.  Educate Patient  Teach the patient about the medication including name adverse effects, drug interactions.  Teach the patient about the signs of hypotension, hyperkalemia, and renal failure. If patient is taking lithium discuss the signs of lithium toxicity.
  • 17. Test Questions 1. Which of these patients would most likely be treated with an ACE inhibitor? a) A 38-year old women who has become hypertensive in the last trimester of her pregnancy. b) A 78-year old man who just had a heart attack and is in renal failure. c) A 60-year old man who is a diabetic and suffers from hypertension. d) A 72-year old female with a history of hypertenstion who comes to the ER in septic shock.
  • 18. Test Questions 2. Which statement by a patient taking ACE inhibitors demonstrates the patient’s understanding of the medication? a) “I don’t need to exercise because the medication will make me better.” b) “If I feel weak or faint I should take my medication, because it will make me feel better.” c) “I can use salt substitutes instead of the real thing.” d) “If I develop a cough that does not go away I should call my doctor.”
  • 19. Test Questions 1. Which of these lab values would be a contraindication for taking an ACE inhibitor? a) Potassium 3.3 b) Potassium 5.6 c) BUN 10 d) Creatinine 1.2
  • 20. Test Answers with Rationale 1. c is the correct answer. a, b, and d all have contraindications for giving an ACE inhibitor. 2. d is the correct answer. a is wrong because exercise should be encouraged. b is wrong because weakness and syncope are signs that the patient may be hypotensive. c is wrong because salt substitutes are high in potassium and should be used with caution in patients on ACE inhibitors. 3. a is the right answer. Hyperkalemia is a contraindication for ACE inhibitors.
  • 21. References  Karch, A. (2011). Focus on nursing pharmacology (5th ed.). Philadephia, PA: Wolters Kluwer | Lippincott Williams & Wilkins.  Lehne, R. (2007). Pharmacology for nursing care (6th ed.). St. Louis, MO: Saunders|Elsevier.  Solski, L. V. & Longyhore. (2008). Prevention of type 2 diabetes mellitus with angiotensin-converting- enzyme inhibitors. American Journal of Health- System Pharmacy, 65(10): 935-40.  Waterfield, J. (2008). ACE inhibitors: use, action, and prescribing rationale. Nurse Prescribing, 6(3): 110-4.